Practice ABC of chronic obstructive pulmonary disease Pharmacological management—inhaled treatment BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7555.1439 (Published 15 June 2006) Cite this as: BMJ 2006;332:1439 Article Related content Metrics Responses Peer review Related articles Paper Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial Published: 13 May 2000; BMJ 320 doi:10.1136/bmj.320.7245.1297 See more RSV: Paediatricians call on government to expedite infant vaccination programme BMJ March 20, 2024, 384 q706; DOI: https://doi.org/10.1136/bmj.q706 Doctors are told to ration salbutamol amid shortage BMJ March 15, 2024, 384 q673; DOI: https://doi.org/10.1136/bmj.q673 Coroner warns of “multiple failures” that contributed to child’s death from asthma BMJ March 13, 2024, 384 q641; DOI: https://doi.org/10.1136/bmj.q641 Montelukast: Regulator reviewing asthma drug over concerns about mental health effects BMJ March 05, 2024, 384 q563; DOI: https://doi.org/10.1136/bmj.q563 Asthma: Four in 10 patients do not receive timely follow-up after hospital admission, finds study BMJ March 05, 2024, 384 q564; DOI: https://doi.org/10.1136/bmj.q564